Comments
Loading...
Pliant Therapeutics (PLRX) Forecast
NewsEarningsPliant Therapeutics (PLRX) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestPliant Therapeutics (NASDAQ:PLRX) Stock Quotes, Forecast and News Summary
Pliant Therapeutics Stock (NASDAQ: PLRX) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Pliant Therapeutics (PLRX) stock?
You can purchase shares of Pliant Therapeutics (NASDAQ:PLRX) through any online brokerage.
Who are Pliant Therapeutics (PLRX) competitors?
Other companies in Pliant Therapeutics’s space includes: Third Harmonic Bio (NASDAQ:THRD), Theravance Biopharma (NASDAQ:TBPH), Zevra Therapeutics (NASDAQ:ZVRA), GH Research (NASDAQ:GHRS) and SNDL (NASDAQ:SNDL).
What is the forecast, or price target, for Pliant Therapeutics (PLRX) stock?
Pliant Therapeutics has a consensus price target of $40.62.
What is the current price for Pliant Therapeutics (PLRX)?
The stock price for Pliant Therapeutics (NASDAQ: PLRX) is $12.99 last updated November 21, 2024 at 10:56 AM EST.
Does Pliant Therapeutics (PLRX) pay a dividend?
There are no upcoming dividends for Pliant Therapeutics.
When is Pliant Therapeutics (NASDAQ:PLRX) reporting earnings?
Pliant Therapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.
Is Pliant Therapeutics (PLRX) going to split?
There is no upcoming split for Pliant Therapeutics.
What sector and industry does Pliant Therapeutics (PLRX) operate in?
Pliant Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.